References
- Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin [Internet] 2017 [cited 2019 Apr 4]; 67(2):93–99. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28094848
- IARC working group on the evaluation of carcinogenic risks to humans. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum [Internet] 2012 [cited 2019 Aug 5]; 100:1–441. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23189750
- Vescovo T, Pagni B, Piacentini M, et al. Regulation of autophagy in cells infected with oncogenic human viruses and its impact on cancer development. Front Cell Dev Biol. 2020;8:47.
- Schiffman M, Doorbar J, Wentzensen N, et al. Carcinogenic human papillomavirus infection. Nat Rev Dis Prim. [Internet] 2016 [cited 2019 Jul 23]; 2:16086. Available from: http://www.nature.com/articles/nrdp201686
- Darnell GA, Schroder WA, Antalis TM, et al. Human Papillomavirus E7 requires the protease calpain to degrade the retinoblastoma protein. J Biol Chem [Internet] 2007 [cited 2019 Apr 4]; 282(52):37492–37500. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17977825
- Pim D, Massimi P, Dilworth SM, et al. Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A. Oncogene [Internet] 2005 [cited 2019 Apr 4]; 24(53):7830–7838. Available from: http://www.nature.com/articles/1208935
- Gillison ML, Trotti AM, Harris J, et al. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet. Internet] 2019 [cited 2019 Jul 23]; 393(10166):40–50.
- Mehanna H, Robinson M, Hartley A, et al. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. Lancet. Internet 2019 [cited 2019 Jul 23]; 393(10166):51–60.
- Rybstein MD, Bravo-San Pedro JM, Kroemer G, et al. The autophagic network and cancer. Nat Cell Biol Internet] 2018 [cited 2019 Jul 23]; 20(3):243–251. Available from: http://www.nature.com/articles/s41556-018-0042–2
- Cosway B, Lovat P. The role of autophagy in squamous cell carcinoma of the head and neck. Oral Oncol. Internet] 2016 [cited 2019 Apr 4]; 54:1–6.
- Antonioli M, Di Rienzo M, Piacentini M, et al. Emerging mechanisms in initiating and terminating autophagy [Internet]. Trends Biochem Sci. cited 2020 Apr 24 2017;42(1):28–41.
- Fimia GM, Corazzari M, Antonioli M, et al. 1 at the crossroad between autophagy and cell death. Oncogene Internet] 2013 [cited 2019 Jul 25]; 32(28):3311–3318. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23069654
- Cianfanelli V, Fuoco C, Lorente M, et al. AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation. Nat Cell Biol. 2015 cited 2014 Dec 2;17:(1):20–30. . Internet.
- Fimia GM, Stoykova A, Romagnoli A, et al. Ambra1 regulates autophagy and development of the nervous system. Nature. Internet] 2007 [cited 2019 Apr 4]; 447:1121–1125. Available from:
- Ellis R, Tang D, Nasr B, et al. Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas. Br J Dermatol. Internet 2020 [cited 2020 Apr 24]; 182:156–165. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31056744
- Falasca L, Torino F, Marconi M, et al. AMBRA1 and SQSTM1 expression pattern in prostate cancer. Apoptosis. Internet 2015 [cited 2019 Apr 4]; 20(12):1577–1586.
- New J, Arnold L, Ananth M, et al. Secretory autophagy in cancer-associated fibroblasts promotes head and neck cancer progression and offers a novel therapeutic target. Cancer Res. Internet 2017 [cited 2019 Apr 15]; 77(23):6679–6691.
- Antonioli M, Ciccosanti F, Dengjel J, et al. Methods to study the BECN1 interactome in the course of autophagic responses. Methods Enzymol. Internet] 2017 [cited 2019 Apr 4]; 587:429–445. Available from: https://www.sciencedirect.com/science/article/pii/S0076687916303421
- Wright TJ, McKee C, Birch-Machin MA, et al. Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy. Clin Exp Dermatol Internet] 2013 [cited 2019 Jul 23]; 38(4):421–423. Available from:
- Claerhout S, Verschooten L, Van Kelst S, et al. Concomitant inhibition of AKT and autophagy is required for efficient cisplatin-induced apoptosis of metastatic skin carcinoma. Int J Cancer Internet 2010 [cited 2019 Jul 23]; 127(12):2790–2803. Available from:
- Dowdle WE, Nyfeler B, Nagel J, et al. Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nat Cell Biol. Internet 2014 [cited 2019 Apr 4]; 16(11):1069–1079.
- Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. JNCI J Natl Cancer Inst Internet] 2008 [cited 2019 Apr 4]; 100(4):261–269. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18270337
- Antonioli M, Albiero F, Nazio F, et al. AMBRA1 interplay with cullin E3 ubiquitin ligases regulates autophagy dynamics. Dev Cell. Internet] 2014 [cited 2017 Aug 18]; 31(6):734–746.
- Pagliarini V, Wirawan E, Romagnoli A, et al. Proteolysis of Ambra1 during apoptosis has a role in the inhibition of the autophagic pro-survival response. Cell Death Differ. Internet] 2012 [cited 2019 Apr 16]; 19:1495–1504. Available from: http://www.nature.com/articles/cdd201227
- Choi Y, Bowman JW, Jung JU. Autophagy during viral infection — a double-edged sword. Nat Rev Microbiol Internet 2018 [cited 2019 Apr 15]; 16(6):341–354. Available from: http://www.nature.com/articles/s41579-018-0003–6
- Surviladze Z, Sterk RT, DeHaro SA, et al. Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-Kinase/Akt/mTOR Pathway and inhibition of autophagy. J Virol Internet 2013 [cited 2019 Apr 15]; 87(5):2508–2517. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23255786
- Zhang B, Song Y, Sun S, et al. 11 early protein E6 activates autophagy by repressing AKT/mTOR and Erk/mTOR. J Virol Internet] 2019 [cited 2020 Aug 24]; 93(12). doi: https://doi.org/10.1128/JVI.00172-19
- Zhou X, Münger K. Expression of the human papillomavirus type 16 E7 oncoprotein induces an autophagy-related process and sensitizes normal human keratinocytes to cell death in response to growth factor deprivation. Virology Internet 2009 [cited 2015 Mar 2]; 385(1):192–197. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2673705&tool=pmcentrez&rendertype=abstract
- Tingting C, Shizhou Y, Songfa Z, et al. Human papillomavirus 16E6/E7 activates autophagy via Atg9B and LAMP1 in cervical cancer cells. Cancer Med Internet 2019 [cited 2020 Aug 24]; 8(9):4404–4416. Available from: /pmc/articles/PMC6675746/?report=abstract
- Cheng HY, Zhang YN, Wu QL, et al. Expression of beclin 1, an autophagy-related protein, in human cervical carcinoma and its clinical significance. Eur J Gynaecol Oncol. Internet 2012 [cited 2019 Apr 15]; 33:15–20. Available from:http://www.ncbi.nlm.nih.gov/pubmed/22439399
- Lai K, Matthews S, Wilmott JS, et al. Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients. BMC Cancer. Internet 2018 [cited 2019 Apr 15]; 18(1):624.
- Wu Y, Wang X, Guo H, et al. Synthesis and screening of 3-MA derivatives for autophagy inhibitors. Autophagy Internet] 2013 [cited 2020 Oct 7]; 9(4):595–603. Available from: /pmc/articles/PMC3627673/?report=abstract
- White JS, Weissfeld JL, Ragin CCR, et al. The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. Oral Oncol. Internet] 2007 [cited 2019 Jul 23]; 43(7):701–712.
- Rheinwald JG, Beckett MA. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 1981;41(5):1657-63.
- Di Rienzo M, Antonioli M, Fusco C, et al. Autophagy induction in atrophic muscle cells requires ULK1 activation by TRIM32 through unanchored K63-linked polyubiquitin chains. Sci Adv. Internet 2019 [cited 2019 May 23]; 5(5):eaau8857.
- Refolo G, Ciccosanti F, Di Rienzo M, et al. Negative regulation of mitochondrial antiviral signaling protein-mediated antiviral signaling by the mitochondrial protein LRPPRC during hepatitis C virus infection. Hepatology Internet] 2019 [cited 2019 Apr 4]; 69(1):34–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30070380
- Schache AG, Powell NG, Cuschieri KS, et al. HPV-related oropharynx cancer in the United Kingdom: an evolution in the understanding of disease etiology. Cancer Res. Internet] 2016 [cited 2019 Jul 23]; 76(22):6598–6606.
- Robinson M, James J, Thomas G, et al. Quality assurance guidance for scoring and reporting for pathologists and laboratories undertaking clinical trial work. J Pathol Clin Res. Internet 2019 [cited 2019 Jul 23]; 5(2):91–99.
- Donà MG, Rollo F, Pichi B, et al. Evaluation of the Xpert® HPV assay in the detection of Human Papillomavirus in formalin-fixed paraffin-embedded oropharyngeal carcinomas. Oral Oncol. Internet 2017 [cited 2019 Jul 23]; 72:117–122.
- Donà MG, Spriano G, Pichi B, et al. Human papillomavirus infection and p16 overexpression in oropharyngeal squamous cell carcinoma: a case series from 2010 to 2014. Future Microbiol Internet 2015 [cited 2019 Jul 23]; 10(8):1283–1291. http://www.ncbi.nlm.nih.gov/pubmed/26228531